Company Filing History:
Years Active: 2010
Title: Jörn Piel: Innovator in Antitumor Compound Biosynthesis
Introduction
Jörn Piel is a notable inventor based in Jena, Germany. He has made significant contributions to the field of biosynthesis, particularly in the development of antitumor compounds. His work has implications for cancer treatment and showcases the potential of natural products in pharmaceutical applications.
Latest Patents
Jörn Piel holds a patent for a gene cluster of pederin biosynthesis genes. This invention involves the cloning, sequencing, and analysis of a gene cluster that encodes a modular polyketide synthase enzyme. This enzyme is crucial for the biosynthesis of the antitumor compound pederin. The patent represents a groundbreaking example of genes from an unculturable symbiont that encode the biosynthesis of a drug candidate.
Career Highlights
Throughout his career, Jörn Piel has been associated with prestigious institutions. He has worked at the Rheinische Friedrich-Wilhelms-Universität Bonn, contributing to research and innovation in his field. His academic background and research endeavors have positioned him as a key figure in biosynthetic research.
Collaborations
Due to space constraints, the details of Jörn Piel's collaborations will not be included.
Conclusion
Jörn Piel's innovative work in the biosynthesis of antitumor compounds highlights the importance of natural products in drug development. His contributions continue to influence the field and pave the way for future research in cancer treatment.